HIV :: 17 AIDS cases reported in Q3 – HK

In the third quarter, 96 people – 81 men and 15 women – tested HIV positive, bringing the cumulative number of infections to 3,100, the Centre for Health Protection says.

HIV :: Number of People with HIV in Latin America and the Caribbean Rises to 2 Million

Almost two million people with HIV live in Latin America and the Caribbean today, and the number of new infections in 2006 rose to 167,000, 12,000 more than in 2004, according to the new AIDS Epidemic Update, an annual report on the latest developments in the epidemic released today by UNAIDS/WHO. By the end of 2006, the total number of people with the virus was estimated to reach 1,950,000, 210,000 more than in 2004, the report said.

Cervical Cancer :: PAHO Recognized for Cervical Cancer Elimination Efforts

The Pan American Health Organization (PAHO) was recognized today for its efforts in cervical cancer prevention, receiving the ?Women in Government Presidential Leadership Award for a Commitment to the Elimination of Cervical Cancer? from the non-profit, bi-partisan organization that represents women state legislators in the United States.

Lung Cancer :: Nanoparticle tumor suppressor shows promise

Laboratory results with the NPRL2 tumor suppressor gene demonstrated that infusions of NPRL2 nanoparticles in combination with cisplatin resulted in a 90 percent inhibition of tumor growth in human lung cancer cells compared to control treatments, reported Introgen Therapeutics, Inc. (Nasdaq: INGN – News).

Cancer :: Germ – Chemo Combo Fights Cancer

Bacteria that can cause deadly infections in humans and animals have shown promise in treating cancer by ?eating? tumors from the inside out. Now, two new studies at the Johns Hopkins Kimmel Cancer Center have demonstrated that, combined with specially-packaged anti-cancer drugs, the bacterial therapy?s prospects for cancer eradication have dramatically improved.

Diabetes :: Patient Support Program Offers Savings on Glumetza Therapy for Type 2 Diabetes

King Pharmaceuticals, Inc. (NYSE: KG) and Depomed, Inc. (NASDAQ: DEPO) today announced the launch of a new program that will provide support for patients with diabetes who are receiving treatment with Glumetza (metformin hydrochloride extended-release tablets), a new once-daily extended-release metformin formulation that features AcuForm drug-delivery technology.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack